[go: up one dir, main page]

AR066975A1 - Envase - Google Patents

Envase

Info

Publication number
AR066975A1
AR066975A1 ARP080102507A ARP080102507A AR066975A1 AR 066975 A1 AR066975 A1 AR 066975A1 AR P080102507 A ARP080102507 A AR P080102507A AR P080102507 A ARP080102507 A AR P080102507A AR 066975 A1 AR066975 A1 AR 066975A1
Authority
AR
Argentina
Prior art keywords
container
tablets
oxygen
water
inert atmosphere
Prior art date
Application number
ARP080102507A
Other languages
English (en)
Inventor
Neil Hyde
Neil Davis John Alfred Hyde
John Alfred Davis
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of AR066975A1 publication Critical patent/AR066975A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
    • B65D81/20—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
    • B65D81/2069—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)

Abstract

Un envase impermeable al agua y al oxigeno. El envase encierra una atmosfera inerte que contiene tabletas medicinales, en donde las tabletas contienen buprenorfina o una sal éster de la misma.
ARP080102507A 2007-06-13 2008-06-12 Envase AR066975A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0711376A GB2450117A (en) 2007-06-13 2007-06-13 A water- and oxygen-occlusive blister tablet pack

Publications (1)

Publication Number Publication Date
AR066975A1 true AR066975A1 (es) 2009-09-23

Family

ID=38331999

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102507A AR066975A1 (es) 2007-06-13 2008-06-12 Envase

Country Status (16)

Country Link
US (1) US8697718B2 (es)
EP (1) EP2155139B1 (es)
CN (1) CN101715337A (es)
AR (1) AR066975A1 (es)
AU (3) AU2008263682A1 (es)
BR (1) BRPI0812476A2 (es)
CA (1) CA2690036C (es)
CL (1) CL2008001744A1 (es)
ES (1) ES2626628T3 (es)
GB (1) GB2450117A (es)
MX (1) MX2009013535A (es)
NZ (1) NZ581604A (es)
PE (1) PE20090373A1 (es)
TW (1) TWI527579B (es)
WO (1) WO2008152347A2 (es)
ZA (1) ZA200908588B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056309T2 (hu) 2011-09-19 2022-02-28 Orexo Ab Buprenorfint és naloxont tartalmazó szublingvális, abúzus-rezisztens tabletták
CN108079221A (zh) * 2018-02-27 2018-05-29 湖南尔康制药股份有限公司 一种维c银翘泡腾片
CN108313367A (zh) * 2018-02-27 2018-07-24 湖南尔康制药股份有限公司 一种充惰性气体包装的维c银翘片

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549204A (en) * 1992-02-26 1996-08-27 Toren Consulting Pty. Ltd. Blister packs
US5432178A (en) * 1992-09-18 1995-07-11 Ono Pharmaceutical Co., Ltd. Amidinophenol derivatives
US5858490A (en) * 1993-06-10 1999-01-12 Nkk Corporation Film formed from polyethylene-2,6-naphthalate resin, process for producing said film and package using said film
CH689305A5 (de) * 1994-08-23 1999-02-15 Alusuisse Lonza Services Ag Blisterpackung.
US5799463A (en) * 1996-05-28 1998-09-01 Mitsubishi Gas Chemical Company, Inc. Method for preservation of article
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
CA2388123A1 (en) * 1999-10-23 2001-05-03 Sonja Joran Ugarkovic Oral dosage form comprising a salt of morphine or a morphine derivative
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US7025992B2 (en) * 2001-02-14 2006-04-11 Gw Pharma Limited Pharmaceutical formulations
EP1241110A1 (en) * 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
SI21302A (sl) * 2002-10-11 2004-04-30 LEK farmacevtska dru�ba d.d. Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
WO2004064809A1 (en) * 2003-01-22 2004-08-05 Sandoz Ag Solid pharmaceutical composition comprising ramipril
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
WO2005074603A2 (en) * 2004-02-03 2005-08-18 Abbott Laboratories Aminobenzoxazoles as therapeutic agents
EP1750675B1 (en) * 2004-06-02 2008-10-29 Galephar M/F Stable oral pharmaceutical compositions of buprenorphine and salt thereof
BRPI0519561A2 (pt) * 2004-12-27 2009-01-27 King Pharmaceuticals Res & Dev composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
EP1772395B1 (de) * 2005-10-05 2011-03-09 Berlin-Chemie Ag Pharmazeutische Schutzverpackung
US8632801B2 (en) * 2005-12-28 2014-01-21 Alza Corporation Stable therapeutic formulations
WO2007084818A2 (en) * 2006-01-10 2007-07-26 Pipex, Inc. Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases

Also Published As

Publication number Publication date
TW200911217A (en) 2009-03-16
WO2008152347A3 (en) 2009-04-23
GB0711376D0 (en) 2007-07-25
PE20090373A1 (es) 2009-04-01
US8697718B2 (en) 2014-04-15
US20100292265A1 (en) 2010-11-18
GB2450117A (en) 2008-12-17
CN101715337A (zh) 2010-05-26
CA2690036C (en) 2016-07-05
ES2626628T3 (es) 2017-07-25
BRPI0812476A2 (pt) 2014-12-02
CL2008001744A1 (es) 2009-05-22
AU2016203632A1 (en) 2016-06-23
MX2009013535A (es) 2010-02-22
TWI527579B (zh) 2016-04-01
CA2690036A1 (en) 2008-12-18
EP2155139A2 (en) 2010-02-24
AU2014203766A1 (en) 2014-07-31
WO2008152347A2 (en) 2008-12-18
ZA200908588B (en) 2011-02-23
AU2008263682A1 (en) 2008-12-18
AU2014203766B2 (en) 2016-06-09
NZ581604A (en) 2012-08-31
EP2155139B1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
UA110486C2 (ru) Пристрій і спосіб для упаковування тонкостінних корпусів контейнерів, і група навантажувального обладнання тонкостінних корпусів контейнерів
AR062874A1 (es) Composiciones farmaceuticas que contienen rosuvastatina calcio
DE602006009226D1 (de) Nadelfreie transdermale transportvorrichtung
CR8882S (es) Sistema contenedor de alimentos que se pueden almacenar
CL2007002758A1 (es) Un procedimiento para la provision de un recipiente cerrado con una atmosfera interna con una concentracion de oxigeno menor que el ambiente, que comprende proporcionar un recipiente permeable al oxigeno, y exponerlo a un material absorbente de oxige
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
AR075834A1 (es) Dispositivo para la administracion intranasal
SI2600838T1 (sl) Farmacevtska odmerna oblika, ki obsega 6'-fluoro-(N-metil- ali N,N-dimetil-)-4-fenil-4',9'-dihidro-3'H-spiro(cikloheksan-1,1'-pirano (3,4,b)indol)-4-amin
EP2752233A4 (en) OXYGEN ABSORPTION AGENT AND OXYGEN ABSORBING PACKING THEREWITH
CY1110097T1 (el) Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων
CL2012003012A1 (es) Composicion farmaceutica oral de liberacion prolongada que comprenden a) al menos un material de liberacion prolongada y b) hidromorfona o una sal y naloxona o una sal en una relacion 2:1 a 1:3; metodo de preparacion.
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
AR066975A1 (es) Envase
UA100850C2 (ru) Средство для борьбы с паразитами на животных
EP2965809A4 (en) OXYGEN ABSORBING COMPOSITION AND FORM BODY AND PACKAGING THEREWITH
DK2012701T3 (da) Aftrækkelig emballage til sterilisering
CL2013000291A1 (es) Método para envasar esporas fúngicas que comprende reducir la actividad acuosa inicial de las esporas a menos de 0,3, colocar las esporas denrto de un envase impermeable al vapor de agua y mantener las esporas en el envasado durante al menos dos días a temperaturas entre 15 y 25 grados celcius.
CL2008003375A1 (es) Pastilla antihumedad aromatizante comprendida por material desecante, con un dispositivo aromatizador que incluye un envase con parte de su superficie impermeable en contacto con la pastilla y otra superficie en contacto con el ambiente que tiene membrana permeable de liberacion de agente aromatizador contenido en el envase.
EP2094337A4 (en) Gaseous sterilization of impermeable containers through use of porous material
MX341134B (es) Composicion microbicida.
CL2012002461A1 (es) Empaque que contiene una pluralidad de artículos absorbentes desechables y que comprende un precorte y un gráfico de un personaje en combinación con el precorte.
DE602006008339D1 (en) Zolpidemtabletten
NL1031670A1 (nl) Een kraagvormige afscherming rondom het halsgebied, opgebouwd uit lood en/of loodequivalent materiaal gecombineerd met weefselequivalent materiaal met als primair doel het verminderen van uitgezonden gammastraling vanuit de schildklier na behandeling met Jodium 131, Stapelkraag genoemd.
ITFI20040084A1 (it) Dispositivo per la movimentazione dei logs
CN301019494S (zh) 药品包装盒(999乌鸡白凤丸)

Legal Events

Date Code Title Description
FB Suspension of granting procedure